Succinic Acid

Succinic Acid

SCHEMBL6236115

N=C(N)NCCOCCO.O=C(O)CCC(=O)O

nearest known ligand 0.36

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRB1CDK4CDK6CHRM2CHRM3DPP4DRD2DRD3DRD4EGFRHRH1HTR1BHTR1DHTR1FHTR2AHTR2CHTR4SLC6A2SLC6A4

The experimentally established mechanism targets of Succinic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.34
MAPK1 P28482 1/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
LMNA P02545 3/20 0.32
ATG4B Q9Y4P1 1/20 0.32
KDM4E B2RXH2 1/20 0.31
KDM5C P41229 1/20 0.31
PHF8 Q9UPP1 1/20 0.31
KDM2A Q9Y2K7 1/20 0.31
ALKBH5 Q6P6C2 1/20 0.31
SUCNR1 Q9BXA5 1/20 0.31
EGLN1 Q9GZT9 1/20 0.31
GAA P10253 1/20 0.31
ITGB3 P05106 2/20 0.31
ITGA2B P08514 2/20 0.31
CAMK2A Q9UQM7 1/20 0.30
ALOX15 P16050 1/20 0.30
CA2 P00918 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17030150 0.87 SMN1; SMN2 (0.37) SMN1; SMN2MEN1KMT2ALMNAITGB3
SCHEMBL2335798 0.87 TSHR (0.46) TSHRMAPK1SMN1; SMN2MEN1KMT2A
SCHEMBL6412590 0.85 MEN1 (0.48) TSHRMAPK1SMN1; SMN2MEN1KMT2A
Hydrochloric Acid SCHEMBL17022780 0.85 TSHR (0.43) TSHRMAPK1SMN1; SMN2MEN1KMT2A
SCHEMBL17030209 0.84 TSHR (0.42) TSHRSMN1; SMN2MEN1KMT2ALMNA
Hydrochloric Acid SCHEMBL28182299 0.83 MEN1 (0.46) TSHRMAPK1SMN1; SMN2MEN1KMT2A
Succinic Acid SCHEMBL27911601 0.83 TSHR (0.46) TSHRMAPK1MEN1KMT2ALMNA
Succinic Acid SCHEMBL28041968 0.83 TSHR (0.46) TSHRMAPK1MEN1KMT2ALMNA
SCHEMBL16353829 0.80 CA12 (0.40) TSHRMAPK1SMN1; SMN2MEN1KMT2A
Di(Hydroxyethyl)Ether SCHEMBL29046519 0.79 TSHR (0.34) TSHRMAPK1MEN1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12569427-B2 Makeup application method KAO CORPORATION (JP) 2026-03-10 US disclosed
US-20230172836-A1 MAKEUP APPLICATION METHOD KAO CORPORATION (JP) 2023-06-08 US disclosed
EP-4129417-A1 MAKEUP APPLICATION METHOD Kao Corporation (JP) 2023-02-08 EP disclosed
US-11497290-B2 Method for producing coating film on skin by electrostatic spraying KAO CORPORATION (JP) 2022-11-15 US disclosed
US-11229583-B2 Multilayer nanofiber sheet and adhesion method for same KAO CORPORATION (JP) 2022-01-25 US disclosed
CN-112829419-A Multilayer nanofiber sheet and method of attaching the same 花王株式会社 2021-05-25 CN disclosed
EP-3549758-B1 MULTILAYER NANOFIBER SHEET AND ADHESION METHOD FOR SAME KAO CORP (JP) 2021-03-17 EP disclosed
EP-3366270-B1 METHOD FOR PRODUCING COATING FILM KAO CORP (JP) 2021-02-17 EP disclosed
EP-3549758-A1 MULTILAYER NANOFIBER SHEET AND ADHESION METHOD FOR SAME Kao Corporation (JP) 2019-10-09 EP disclosed
US-20190282460-A1 MULTILAYER NANOFIBER SHEET AND ADHESION METHOD FOR SAME KAO CORPORATION (JP) 2019-09-19 US disclosed
US-20190053602-A1 METHOD FOR PRODUCING COATING FILM KAO CORPORATION (JP) 2019-02-21 US disclosed
EP-3366270-A1 METHOD FOR PRODUCING COATING FILM Kao Corporation (JP) 2018-08-29 EP disclosed
EP-1174124-B1 PREPARATIONS FOR THE PERCUTANOUS ADMINISTRATION OF HYDROPHILIC AGENTS KAO CORP (JP) 2005-06-15 EP disclosed
US-6827944-B2 Water soluble active material and polymer mixture KAO CORPORATION (JP) 2004-12-07 US disclosed
EP-1174124-A9 PERCUTANEOUS ADMINISTRATION PREPARATIONS Kao Corporation (JP) 2002-04-03 EP disclosed
EP-1174124-A1 PERCUTANEOUS ADMINISTRATION PREPARATIONS Kao Corporation (JP) 2002-01-23 EP disclosed
US-6187955-B1 A MOISTURIZER FOR SOFTENING SKINS; USEFUL AS COMPONENTS OF COSMETIC FORMULATIONS KAO CORPORATION (JP) 2001-02-13 US disclosed
US-5723133-A GUANIDINE WITH ORGANIC ACID FOR SKIN SOFTENING KAO CORPORATION (JP) 1998-03-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230172836-A1 MAKEUP APPLICATION METHOD CUTA, PNN, PFN1 TSHR 4676/4885MAPK1 1733/4885SMN1; SMN2 871/4885
US-12569427-B2 Makeup application method LMNB1, LMNB2, PFN1 TSHR 3911/4885MAPK1 3121/4885SMN1; SMN2 237/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.